Protocol No.: A032201
- Title
- Short TeRm Intensified Pembrolizumab (KEytruda) and Tivozanib for High-Risk Renal Cell Carcinoma - STRIKE
- Principal Investigator
- Kolodney, Joanna
- Phase
- III
- Age Group
- Adult
- Applicable Disease Site
- Other
- Participating Institutions
- Camden Clark Medical Center
- Mary Babb Randolph Cancer Center
- Contacts
- Sabrina Rexroad, RN
- Research Nurse
- Email: sabrina.rexroad1@wvumedicine.org
- Valli White, RN
- Research Nurse
- Phone: +1 304-264-1220
- Email: valli.white@wvumedicine.org
- Layla Tannoury
- Clinical Research Specialist
- Phone: +1 304-424-2585
- Email: layla.tannoury@wvumedicine.org
- Nnennaya Opara
- Clinical Research Specialist
- Phone: +1 681-342-1000
- Email: nnennaya.opara1@wvumedicine.org
- Jill Stone, LPN
- Research Specialist
- Phone: +1 304-634-4417
- Email: jill.stone@hsc.wvu.edu